Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Sacher

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
Nature Chemical Biology|February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
The New England Journal of Medicine|September 21, 2020
KRAS<sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, John H Strickler, et al.
Journal of Molecular Biology|October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer CellsPunit Saraon, Jamie Snider, Wiebke Schormann, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
Nature Chemical Biology|February 26, 2020
A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.
The New England Journal of Medicine|September 21, 2020
KRAS<sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, John H Strickler, et al.
Journal of Molecular Biology|October 18, 2021
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer CellsPunit Saraon, Jamie Snider, Wiebke Schormann, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Nature Medicine|December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
Pageof 6